41102 - Medicines and Healthcare products Regulatory Agency (Answered)

Mr Virendra Sharma
To ask the Secretary of State for Health, what plans he has for the Medicines and Healthcare Products Regulatory Agency to contribute to the Government's aim of reducing the regulatory burden on business by £10 billion in 2016-17; and if he will make a statement.

George Freeman

The Medicines and Healthcare products Regulatory Agency (MHRA), with the Department’s other arm’s length bodies, is expected to contribute to the Department’s contribution to the Business Impact Target and the continued drive to reduce the burden of regulations. The MHRA has developed, in partnership with industry, a burden reduction plan to deliver proportionate regulation and minimise the regulatory burden on industry, while safeguarding public health. Industry partners have been asked to identify potential monetary savings from these actions. The Department will hold the MHRA to account for delivery against this plan.